100 years of physiology, discrimination and wonder

por Russell‐Jones, David, Herring, Roselle
Publicado 2021

Identification of barriers to insulin therapy and approaches to overcoming them

por Russell‐Jones, David, Pouwer, Frans, Khunti, Kamlesh
Publicado 2017

Leveraging advances in diabetes technologies in primary care: a narrative review

por Bode, Bruce, King, Aaron, Russell-Jones, David, Billings, Liana K.
Publicado 2021

Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19

por Kotwica, Aleksandra, Knights, Harry, Mayor, Nikhil, Russell-Jones, Emma, Dassios, Theodore, Russell-Jones, David
Publicado 2021

Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency

por McMillan, Carolyn V, Bradley, Clare, Gibney, James, Russell-Jones, David L, Sönksen, Peter H
Publicado 2006

Projected long‐term outcomes in patients with type 1 diabetes treated with fast‐acting insulin aspart vs conventional insulin aspart in the UK setting

por Russell‐Jones, David, Heller, Simon R., Buchs, Sarah, Sandberg, Anna, Valentine, William J., Hunt, Barnaby
Publicado 2017

Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes

por Philis‐Tsimikas, Athena, Bajaj, Harpreet S., Begtrup, Kamilla, Cailleteau, Roman, Gowda, Amoolya, Lingvay, Ildiko, Mathieu, Chantal, Russell‐Jones, David, Rosenstock, Julio
Publicado 2022

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial

por Mathieu, Chantal, Bode, Bruce W., Franek, Edward, Philis‐Tsimikas, Athena, Rose, Ludger, Graungaard, Tina, Birk Østerskov, Anne, Russell‐Jones, David
Publicado 2018

Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ≥8%, ≥64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiL...

por Davies, Melanie J., Rosenstock, Julio, Ali, Amar, Russell‐Jones, David, Souhami, Elisabeth, Palmer, Karen, Ji, Chen, Niemoeller, Elisabeth, Skolnik, Neil
Publicado 2021

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week...

por Russell-Jones, David, Cuddihy, Robert M., Hanefeld, Markolf, Kumar, Ajay, González, Jose G., Chan, Melanie, Wolka, Anne M., Boardman, Marilyn K.
Publicado 2012

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Tr...

por Mathieu, Chantal, Hollander, Priscilla, Miranda-Palma, Bresta, Cooper, John, Franek, Edward, Russell-Jones, David, Larsen, Jens, Tamer, Søren Can, Bain, Stephen C.
Publicado 2013

Insulin Detemir Reduces Weight Gain as a Result of Reduced Food Intake in Patients With Type 1 Diabetes

por Zachariah, Sunil, Sheldon, Ben, Shojaee-Moradie, Fariba, Jackson, Nicola C., Backhouse, Katharine, Johnsen, Sigurd, Jones, Richard H., Umpleby, A. Margot, Russell-Jones, David L.
Publicado 2011

Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance

por Whyte, Martin B, Shojaee-Moradie, Fariba, Sharaf, Sharaf E, Jackson, Nicola C, Fielding, Barbara, Hovorka, Roman, Mendis, Jeewaka, Russell-Jones, David, Umpleby, A Margot
Publicado 2018

Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc A...

por Bowering, Keith, Rodbard, Helena W., Russell-Jones, David, Bode, Bruce, Harris, Stewart, Piletic, Milivoj, Heller, Simon, Woo, Vincent, Babu, Vinay, Dethlefsen, Claus, Mathieu, Chantal
Publicado 2018

Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 di...

por Russell‐Jones, David, Dauchy, Arnaud, Delgado, Elías, Dimitriadis, George, Frandsen, Hans A., Popescu, Luiza, Schultes, Bernd, Strojek, Krzysztof, Bonnemaire, Mireille, Roborel de Climens, Aude, Davies, Melanie
Publicado 2019

Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the Lixi...

por Davies, Melanie J., Russell‐Jones, David, Barber, Thomas M., Lavalle‐González, Fernando J., Galstyan, Gagik R., Zhu, Dalong, Baxter, Mike, Dessapt‐Baradez, Cecile, McCrimmon, Rory J.
Publicado 2019

Intrapulmonary shunting is a key contributor to hypoxia in COVID-19: An update on the pathophysiology

por Mayor, Nikhil, Knights, Harry, Kotwica, Aleksandra, Coppola, Andrew Solomon Joseph, Hunter, Harriet, Jeffreys, Nathan, Morgan, Alexander, Gupta, Shivani, Prentice, James, Macfarlane, Rebecca, Russell-Jones, Emma, Dassios, Theodore, Russell-Jones, David
Publicado 2022

Fecal Enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans

por Pedersen, Camilla, Ijaz, Umer Z., Gallagher, Edith, Horton, Felicity, Ellis, Richard J., Jaiyeola, Etana, Duparc, Thibaut, Russell‐Jones, David, Hinton, Paul, Cani, Patrice D., La Ragione, Roberto M., Robertson, M. Denise
Publicado 2018